Immune Effects of Trastuzumab
<p>Trastuzumab's targeted therapy has become a stronghold for human epidermal growth factor receptor 2 positive breast cancer patients. This humanized monoclonal antibody binds to the extracellular juxta-membrane domain of HER2 and inhibits the proliferation and survival of HER2 dependent...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ivyspring International Publisher
2011-01-01
|
| Series: | Journal of Cancer |
| Online Access: | http://www.jcancer.org/v02p0317.htm |